The Japanese Biochemical Society

3:52 PM - 4:11 PM

[1S10a-04] Development of COVID-19 vaccine in Japan using self-amplifying RNA technology

Wataru Akahata (VLP Therapeutics Japan)

キーテクノロジー:replicon

COVID-19、Vaccine、replicon

wakahata@vlptherapeutics.com

Contents of this site has moved to the member page of The Japanese Biochemical Society: https://member.jbsoc.or.jp/mypage/
You can access the abstracts without credentials by accessing them via the member page.

You need the membership number and password to access the member page. Please contact the journal office for any inquiries.

Journal Office Contact Information:
E-mail:jbs-ho@jbsoc.or.jp
Tel:03(3815)1913 Fax:03(3815)1934

Password